{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,4]],"date-time":"2026-03-04T12:12:25Z","timestamp":1772626345871,"version":"3.50.1"},"reference-count":15,"publisher":"Oxford University Press (OUP)","issue":"12","funder":[{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["AI079590"],"award-info":[{"award-number":["AI079590"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["037856"],"award-info":[{"award-number":["037856"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["036973"],"award-info":[{"award-number":["036973"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000011","name":"Howard Hughes Medical Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000011","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,6,15]]},"DOI":"10.1093\/infdis\/jix208","type":"journal-article","created":{"date-parts":[[2017,5,17]],"date-time":"2017-05-17T15:10:34Z","timestamp":1495033834000},"page":"1883-1887","source":"Crossref","is-referenced-by-count":29,"title":["Suppressor Cell\u2013Depleting Immunotherapy With Denileukin Diftitox is an Effective Host-Directed Therapy for Tuberculosis"],"prefix":"10.1093","volume":"215","author":[{"given":"Shashank","family":"Gupta","sequence":"first","affiliation":[{"name":"Center for Tuberculosis Research, Department of Medicine, Johns Hopkins University, Baltimore, Maryland; and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laurene","family":"Cheung","sequence":"additional","affiliation":[{"name":"Center for Tuberculosis Research, Department of Medicine, Johns Hopkins University, Baltimore, Maryland; and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Supriya","family":"Pokkali","sequence":"additional","affiliation":[{"name":"Center for Tuberculosis Research, Department of Medicine, Johns Hopkins University, Baltimore, Maryland; and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kathryn","family":"Winglee","sequence":"additional","affiliation":[{"name":"Center for Tuberculosis Research, Department of Medicine, Johns Hopkins University, Baltimore, Maryland; and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haidan","family":"Guo","sequence":"additional","affiliation":[{"name":"Center for Tuberculosis Research, Department of Medicine, Johns Hopkins University, Baltimore, Maryland; and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John R.","family":"Murphy","sequence":"additional","affiliation":[{"name":"Center for Tuberculosis Research, Department of Medicine, Johns Hopkins University, Baltimore, Maryland; and"},{"name":"National Emerging Infectious Diseases Laboratories Institute, Boston University, Massachusetts"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"William R.","family":"Bishai","sequence":"additional","affiliation":[{"name":"Center for Tuberculosis Research, Department of Medicine, Johns Hopkins University, Baltimore, Maryland; and"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2017,5,30]]},"reference":[{"key":"key\n\t\t\t\t20180328154955_CIT0001","doi-asserted-by":"crossref","first-page":"2159","DOI":"10.1084\/jem.20062105","article-title":"Expansion and function of Foxp3-expressing T regulatory cells during tuberculosis","volume":"204","author":"Scott-Browne","year":"2007","journal-title":"J Exp Med"},{"key":"key\n\t\t\t\t20180328154955_CIT0002","doi-asserted-by":"crossref","first-page":"2661","DOI":"10.4049\/jimmunol.178.5.2661","article-title":"Cutting edge: regulatory T cells prevent efficient clearance of Mycobacterium tuberculosis","volume":"178","author":"Kursar","year":"2007","journal-title":"J Immunol"},{"key":"key\n\t\t\t\t20180328154955_CIT0003","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1016\/j.immuni.2013.06.003","article-title":"Pathogen-specific Treg cells expand early during Mycobacterium tuberculosis infection but are later eliminated in response to interleukin-12","volume":"38","author":"Shafiani","year":"2013","journal-title":"Immunity"},{"key":"key\n\t\t\t\t20180328154955_CIT0004","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1164\/rccm.201405-0828OC","article-title":"Lung-residing myeloid-derived suppressors display dual functionality in murine pulmonary tuberculosis","volume":"190","author":"Knaul","year":"2014","journal-title":"Am J Respir Crit Care Med"},{"key":"key\n\t\t\t\t20180328154955_CIT0005","doi-asserted-by":"crossref","first-page":"2191","DOI":"10.1002\/eji.201545493","article-title":"Versatile myeloid cell subsets contribute to tuberculosis-associated inflammation","volume":"45","author":"Dorhoi","year":"2015","journal-title":"Eur J Immunol"},{"key":"key\n\t\t\t\t20180328154955_CIT0006","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1093\/protein\/4.4.463","article-title":"Protein engineering of diphtheria-toxin-related interleukin-2 fusion toxins to increase cytotoxic potency for high-affinity IL-2-receptor-bearing target cells","volume":"4","author":"Kiyokawa","year":"1991","journal-title":"Protein Eng"},{"key":"key\n\t\t\t\t20180328154955_CIT0007","doi-asserted-by":"crossref","first-page":"3192","DOI":"10.1182\/blood-2007-06-094615","article-title":"IL-2 immunotoxin denileukin diftitox reduces regulatory T cells and enhances vaccine-mediated T-cell immunity","volume":"110","author":"Litzinger","year":"2007","journal-title":"Blood"},{"key":"key\n\t\t\t\t20180328154955_CIT0008","doi-asserted-by":"crossref","first-page":"e1316","DOI":"10.1371\/journal.pntd.0001316","article-title":"Therapeutic enhancement of protective immunity during experimental leishmaniasis","volume":"5","author":"Divanovic","year":"2011","journal-title":"PLoS Negl Trop Dis"},{"key":"key\n\t\t\t\t20180328154955_CIT0009","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1164\/rccm.201304-0650OC","article-title":"Acceleration of tuberculosis treatment by adjunctive therapy with verapamil as an efflux inhibitor","volume":"188","author":"Gupta","year":"2013","journal-title":"Am J Respir Crit Care Med"},{"key":"key\n\t\t\t\t20180328154955_CIT0010","doi-asserted-by":"crossref","first-page":"4501","DOI":"10.1128\/IAI.70.8.4501-4509.2002","article-title":"Dissemination of Mycobacterium tuberculosis is influenced by host factors and precedes the initiation of T-cell immunity","volume":"70","author":"Chackerian","year":"2002","journal-title":"Infect Immun"},{"key":"key\n\t\t\t\t20180328154955_CIT0011","doi-asserted-by":"crossref","first-page":"2723","DOI":"10.1002\/ijc.22617","article-title":"Depletion of CD4+CD25+ human regulatory T cells in vivo: kinetics of Treg depletion and alterations in immune functions in vivo and in vitro","volume":"120","author":"Mahnke","year":"2007","journal-title":"Int J Cancer"},{"key":"key\n\t\t\t\t20180328154955_CIT0012","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1038\/jid.2011.416","article-title":"Regulatory T cells stimulate B7-H1 expression in myeloid-derived suppressor cells in ret melanomas","volume":"132","author":"Fujimura","year":"2012","journal-title":"J Invest Dermatol"},{"key":"key\n\t\t\t\t20180328154955_CIT0013","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.3109\/10428194.2012.742521","article-title":"A multicenter phase II trial to determine the safety and efficacy of combination therapy with denileukin diftitox and cyclophosphamide, doxorubicin, vincristine and prednisone in untreated peripheral T-cell lymphoma: the CONCEPT study","volume":"54","author":"Foss","year":"2013","journal-title":"Leuk Lymphoma"},{"key":"key\n\t\t\t\t20180328154955_CIT0014","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1097\/CJI.0b013e3181e4752e","article-title":"A pilot study of denileukin diftitox (DD) in combination with high-dose interleukin-2 (IL-2) for patients with metastatic renal cell carcinoma (RCC)","volume":"33","author":"Atchison","year":"2010","journal-title":"J Immunother"},{"key":"key\n\t\t\t\t20180328154955_CIT0015","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1186\/1471-2407-11-515","article-title":"Phase II trial of the regulatory T cell-depleting agent, denileukin diftitox, in patients with unresectable stage IV melanoma","volume":"11","author":"Telang","year":"2011","journal-title":"BMC Cancer"}],"container-title":["The Journal of Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jid\/article-pdf\/215\/12\/1883\/24262355\/jix208.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,3,28]],"date-time":"2018-03-28T22:53:19Z","timestamp":1522277599000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jid\/article\/215\/12\/1883\/3858342"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,5,30]]},"references-count":15,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2017,5,30]]},"published-print":{"date-parts":[[2017,6,15]]}},"URL":"https:\/\/doi.org\/10.1093\/infdis\/jix208","relation":{},"ISSN":["0022-1899","1537-6613"],"issn-type":[{"value":"0022-1899","type":"print"},{"value":"1537-6613","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2017,6,15]]},"published":{"date-parts":[[2017,5,30]]}}}